Skip to main content
logo
Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
13.17
+0.20 (1.54%)
Jul 30, 2026, 1:24 PM EDT - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Biotechnology
36.00K61.00K130.00K84.68M10.65M
Total
36.00K61.00K130.00K84.68M10.65M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
36.00K61.00K130.00K84.68M10.65M
Total
36.00K61.00K130.00K84.68M10.65M